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Introduction 
Aligned with increasing trend in the global prevalence of diabetes including developing 
countries liked Myanmar, major complications of diabetes as diabetic peripheral 
neuropathy (DPN) and neuropathic pain (DPNP) also affect the quality of life in these 
patients (Shaw, Sicree, & Zimmet, 2010; WHO, 2011; WHO, 2014). High prevalence 
rate (30-60%) of DPN was identified in the previous studies with various underlying 
reason as duration of diabetes, type of diabetes (Jaiswal et al., 2017; Lazo Mde et al., 
2014). However, DPN is underdiagnosed because of asymptomatic and unrecognized as 
serious complication of diabetes (Malik et al., 2017; Pop-Busui et al., 2017; Tanenberg, 
2016). The patients with DPN had limitation in the activities of daily living (ADL) 
because of decreased sensation or weakness and pain especially in the feet and hands.  
Prevalence of DPN in Myanmar need to explore the actual situation of DPN and its 
impact on ADL to provide the appropriate healthcare for these patients to prevent 
serious complications of DPN and increase ADL. The purpose of this study was to 
identify the prevalence of DPN and DPNP and their impact on hand and foot function 
and ADL in patients with type 2 diabetes mellitus (T2DM), and to investigate the 
background characteristics of those with or without neuropathy and the different levels 
of pain with increasing severity of DPN in Myanmar.  
Methods 
This study include the participants (n=975) with T2DM visited to outpatient clinics of 
four hospitals in Myanmar, with the including criteria of aged over 25 years, T2DM, 
receiving anti-glycemic treatment. The patients with neuropathy and neuropathic pain 
not due to diabetes, severe illness, mental illness, or alcoholism were excluded from this 
study. The sample size was calculated using the formula described by Kelsey et al. 
(1996) using the estimated prevalence rate, with α = 0.05, power = 0.8, and adding 20% 
of the sample to cover the refusal rate. Every 5th patient who came to the clinics was 
invited to participate and excluded during their follow-up visits, based on the numbers 
of patients in the previous year.  
Data collection was done by interviewing and physical examination after obtaining 
informed consent. Demographic and health history information were collected at the 
start of the interview. Interviewing was done to obtain self-reports of the impact of pain 
on ADL using the Patient Neurotoxicity Questionnaire (PNQ), and a visual analog scale 
(0-100) in Myanmar languages. After the interview, hand grip (TTM Original 
Dynamometer 100 kg, Tustsumi Seisakusho, Co. Ltd., Chiba, Japan), pinch strength 
(B&L Engineering®, Santa Ana, CA, USA), and the Timed Up and Go test (TUG) to 
predict fall risk were examined as physical functioning. Furthermore, 
Semmes-Weinstein Monofilament (SWM) test (Touch-TestTM Sensory Evaluator 5 
Pieces Hand Kit, North Coast Medical Inc., Gilroy, CA, USA) was done at the hands 
(tips of index and ring fingers) and the feet (plantar surface of the distal hallux, and first, 
third, and fifth metatarsal heads).  
Symptoms were defined as the symptoms of paresthesia (numbness, tingling or both). 
Sensory loss was defined as one area of decreased sensation below the normal threshold 
of 4.31 in both feet (Kamei et al., 2005). The presence of pain was determined using a 
VAS (0-100) score of 5-100 (Hawker, Mian, Kendzerska, & French, 2011). The severity 
of DPN was defined using the largest known touch sensation filament size in the SWM 
test. The patients were classified into three groups as: noDPN, people without 
symptoms and sensory loss; DPN, those with some degree of sensory loss but no pain; 
and DPNP, those with pain with or without sensory loss. 
Data analysis was done using SPSS version 23. A logistic regression model was used to 
examine the effects of background characteristics. Furthermore, differences in pain 
intensity among the severities of DPN (DPN 1-5) and the impacts of DPN (patients with 
noDPN, DPN, and DPNP) on physical functions were compared using the 
Kruskal-Wallis H test. The Bonferroni correction was applied after analyzing the 
relationships with difficulties in each component of ADL by Fisher’s exact test. 
This study was approved by the Nursing Science Ethical Review Committee, Graduate 
School of Health Sciences, Okayama University, Japan (approval number D16-05), 
University of Nursing, Yangon, and Department of Medical Research, Myanmar 
(approval number Ethics/DMR/2017 /049).  
Results  
This study included 975 participants, 215 male (22.1%) and 760 female (77.9%). the 
characteristics of the total participant group were: age, 54.90 (±11.24) years; duration of 
diabetes, 5.42 (±5.87) years; BMI, 25.46 (±5.02) kg/m2; duration of oral hypoglycemic 
treatment, 4.99 (±5.53) years; TUG, 7.36 (±3.56) seconds; hand grip, 20 (±7.27) kg, 
finger pinch force, 10 (±3.86) lbs; and VAS, 14 (±28.76).  
In this study, 33.7% (n=329) and 59.5% (n=580) of the participants had DPN and 
DPNP, respectively, with 93.2% total prevalence rate. The patients in DPNP had the 
longest duration of diabetes and taking oral hypoglycemic drugs, and half of them are 
using pain killer (50.3%) and other pain relief techniques (54.1%). Most participants 
(57.9%), including the vast majority of those with DPNP, had abnormal sensation. 
Logistic regression was used to evaluate the background characteristics of DPN after 
analyzing the significant relationship with the chi-squared test. Among three model of 
logistic regression, model (3), with χ2 (24) = 56.731, P < 0.000; Nagelkerke R2 was 
14.5%, with classification accuracy of 93.2% for DPN was the most significant model. 
The longer duration of diabetes (2.8 times in 10-15 years, 3.3 times in over 15 years), 
smoking (5.5 times in the group of quit),  and age (2 times in 40-49 years, 2.5 times in 
50-59 and 60-69 years, 3 times in over 70 years) were associated with a higher 
prevalence of DPN.  
There was no significant difference in DPN severity between the DPN and DPNP group 
according to the Mann-Whitney U test (U = 98354.5, z = 0.84, P = 0.401). In people 
with DPNP, differences in pain intensity were identified across the severities of DPN 
(DPN 1-5) using the Kruskal–Wallis H test. There was no significant difference in VAS 
pain scale scores between people with different severities of DPN in the combined 
groups (DPN and DPNP), (H [4] = 9.13, P = 0.058) and the DPNP group, (H [4] = 4.46, 
P = 0.326). Figure 1 shows the differences in pain intensity across DPN severities in the 
combined and DPNP group.  
TUG duration and hand grip and pinch strengths (dominant hand) were significantly 
different among the groups (H(2) = 23.903, P = 0.000), (H(2) = 34.292, P = 0.000), 
(H(2) = 24.576, P = 0.000), respectively. Patients with DPNP had significantly different 
from those with noDPN and DPN in the pairwise comparison with the longest TUG 
duration and the weakest strength of both hand grip and pinch. Moreover, those with 
DPNP had significantly higher in sensory (H(2) = 205.823, P = 0.000) and motor (H(2) 
= 141.287, P = 0.000) difficulties in PNQ in the pairwise comparison of Kruskal-Wallis 
H test.  
Numbers of difficulties in ADL were also significantly different among the groups 
(H(2) = 168.860, P = 0.00) with the most difficulties in those with DPNP. The common 
difficulties in ADL were sleeping (20.6%), climbing stairs (24.5%), walking (21.3%), 
and work or chores (14.4%). There were also significant differences of difficulties in 
ADL as putting buttons, using a knife, using a fork, using a spoon, using other eating 
utensils, opening doors, sleeping, climbing stairs, walking, working or chores among 
the groups.   
Discussion 
The majority of the participants were found to have DPN in this study, and higher 
prevalence (93.2%)than other studies (Gill et al., 2014; Kim et al., 2015; Lazo Mde et al., 
2014). This may be due to undiagnosed and uncontrolled diabetes in Myanmar (WHO, 
2011). Anti-hyperglycemic treatment also included one of the reasons (Beulens, Hart, 
Kuijs, Kooijman-Buiting, & Rutten, 2015). The background characteristics of DPN as 
age, duration of diabetes, and smoking also supported the findings of previous studies 
(Jaiswal et al., 2017; Jambart et al., 2011; Lazo Mde et al., 2014). The effect of cessation 
of smoking is not understood because of higher risk of DPN in those who quitted smoking 
in this study, likewise in the previous study (Clair, Cohen, Eichler, Selby, & Rigotti, 
2015). Further studies should be focused on this issue.   
Pain intensity was not significantly different across the severity of DPN in this study. 
Our findings were consistent with the previous study of Abbott, 2011 which stated that 
severity of neuropathy had no impact on painful symptoms.  
The finding of longer TUG duration which means higher risk for falls in DPNP 
supported the previous study of Timar et al., 2016. The severity of neuropathy also 
affects functional hand movement in patients with DPN and other types of neuropathy 
(Adams et al., 2015; Yang et al., 2015). In this study, participants who were suffering 
DPNP exhibited the greatest functional hand weakness regardless of the severity of 
DPN. The previous study found that physical strength of the hand affected the 
independence in ADL (Bae et al., 2015). The weakness in hand and difficulties in doing 
work or chores in DPNP were relevant finding in this study.  
Although most of the difficulties (sleeping, balance and walking, work and chores) in 
ADL were the same in the previous study, the study identifies other difficulties as 
putting buttons, using eating utensils and opening doors, and climbing stairs. The 
qualities of difficulties in ADL and nursing care to improve ADL in these patients need 
to explore in the further studies.  
This study had the limitations to generalize total population of Myanmar. First, the 
participants did not accurately represent all ethnic groups in Myanmar. The effect of 
ethnicity on DPN should be identified in future studies because different beliefs, eating 
habits, and health practices also affect health outcomes. Second, our study involved 
more female than male participants. Third, only the monofilament test was used to 
diagnose DPN. Fourth, hemoglobin A1c (HbA1C) levels were not analyzed in this 
study. Finally, only participants taking anti-hyperglycemic treatment were included in 
this study to ascertain their glycemic control because of the underdiagnosis and poor 
control of diabetes in Myanmar (Latt et al., 2016; WHO, 2011).  
Conclusion 
This study highlighted the prevalence and background characteristics of patients with 
DPN, the association between the intensity of pain and the severity of DPN, and the 
difficulties in ADL of patients with T2DM. These findings will be helpful in developing 
future research and healthcare to prevent further complications and disabilities for 
patients with DPN. 
 
 
 
